Literature DB >> 25073864

Quantifying the average of the time-varying hazard ratio via a class of transformations.

Qingxia Chen1, Donglin Zeng, Joseph G Ibrahim, Ming-Hui Chen, Zhiying Pan, Xiaodong Xue.   

Abstract

The hazard ratio derived from the Cox model is a commonly used summary statistic to quantify a treatment effect with a time-to-event outcome. The proportional hazards assumption of the Cox model, however, is frequently violated in practice and many alternative models have been proposed in the statistical literature. Unfortunately, the regression coefficients obtained from different models are often not directly comparable. To overcome this problem, we propose a family of weighted hazard ratio measures that are based on the marginal survival curves or marginal hazard functions, and can be estimated using readily available output from various modeling approaches. The proposed transformation family includes the transformations considered by Schemper et al. (Statist Med 28:2473-2489, 2009) as special cases. In addition, we propose a novel estimate of the weighted hazard ratio based on the maximum departure from the null hypothesis within the transformation family, and develop a Kolmogorov[Formula: see text]Smirnov type of test statistic based on this estimate. Simulation studies show that when the hazard functions of two groups either converge or diverge, this new estimate yields a more powerful test than tests based on the individual transformations recommended in Schemper et al. (Statist Med 28:2473-2489, 2009), with a similar magnitude of power loss when the hazards cross. The proposed estimates and test statistics are applied to a colorectal cancer clinical trial.

Entities:  

Mesh:

Year:  2014        PMID: 25073864      PMCID: PMC4312279          DOI: 10.1007/s10985-014-9301-0

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  9 in total

1.  Estimating average regression effect under non-proportional hazards.

Authors:  R Xu; J O'Quigley
Journal:  Biostatistics       Date:  2000-12       Impact factor: 5.899

2.  Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2002-08-15       Impact factor: 2.373

3.  The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis.

Authors:  L J Wei
Journal:  Stat Med       Date:  1992 Oct-Nov       Impact factor: 2.373

4.  The estimation of average hazard ratios by weighted Cox regression.

Authors:  Michael Schemper; Samo Wakounig; Georg Heinze
Journal:  Stat Med       Date:  2009-08-30       Impact factor: 2.373

5.  Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study.

Authors:  Donglin Zeng; Qingxia Chen; Ming-Hui Chen; Joseph G Ibrahim
Journal:  Biometrika       Date:  2011-12-29       Impact factor: 2.445

6.  Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data.

Authors:  M S Pepe; T R Fleming
Journal:  Biometrics       Date:  1989-06       Impact factor: 2.571

7.  Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions.

Authors:  K R Hess
Journal:  Stat Med       Date:  1994-05-30       Impact factor: 2.373

8.  Breast Cancer Survival Analysis: Applying the Generalized Gamma Distribution under Different Conditions of the Proportional Hazards and Accelerated Failure Time Assumptions.

Authors:  Alireza Abadi; Farzaneh Amanpour; Chris Bajdik; Parvin Yavari
Journal:  Int J Prev Med       Date:  2012-09

9.  Bayesian analysis of generalized odds-rate hazards models for survival data.

Authors:  Tathagata Banerjee; Ming-Hui Chen; Dipak K Dey; Sungduk Kim
Journal:  Lifetime Data Anal       Date:  2007-03-31       Impact factor: 1.429

  9 in total
  4 in total

1.  Quantifying time-varying cause-specific hazard and subdistribution hazard ratios with competing risks data.

Authors:  Guoqing Diao; Joseph G Ibrahim
Journal:  Clin Trials       Date:  2019-06-05       Impact factor: 2.486

2.  Bayesian design of clinical trials using joint models for longitudinal and time-to-event data.

Authors:  Jiawei Xu; Matthew A Psioda; Joseph G Ibrahim
Journal:  Biostatistics       Date:  2022-04-13       Impact factor: 5.279

3.  Estimation of treatment effects and model diagnostics with two-way time-varying treatment switching: an application to a head and neck study.

Authors:  Qingxia Chen; Fan Zhang; Ming-Hui Chen; Xiuyu Julie Cong
Journal:  Lifetime Data Anal       Date:  2020-03-03       Impact factor: 1.429

4.  A marginal estimate for the overall treatment effect on a survival outcome within the joint modeling framework.

Authors:  Floor M van Oudenhoven; Sophie H N Swinkels; Joseph G Ibrahim; Dimitris Rizopoulos
Journal:  Stat Med       Date:  2020-08-24       Impact factor: 2.373

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.